Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1

Status

Recruiting 19Active not recruiting 13Completed 8Withdrawn 4Unknown 4Terminated 4Not yet recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2Other solid neoplasm 1Gastrointestinal 1

Conditions

MMRd/MSI-H Stage II-III Endometrial Cancer 1Locally Advanced Rectal Cancer (LARC) 1Endometrial Neoplasms 1

Interventions

Carboplatin 75Cisplatin 73Bevacizumab 64Radiotherapy 57Drug Therapy 56Capecitabine 56tislelizumab 54Oxaliplatin 54Gemcitabine 46toripalimab 45Paclitaxel 45Specimen Handling 43sintilimab 39pembrolizumab 39anlotinib 38Cyclophosphamide 33130-nm albumin-bound paclitaxel 32Magnetic Resonance Spectroscopy 27Injections 27camrelizumab 26Pemetrexed 26Surgical Procedures, Operative 25lenvatinib 23Docetaxel 23Biopsy 23apatinib 22Etoposide 22Immune Checkpoint Inhibitors 21S 1 (combination) 20Fluorouracil 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × dostarlimab × Clear all
NCT07381777 2026-02-02

IMMUNOSTAR

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Not yet recruiting
270 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

NCT07115927 2025-08-19

RODEO

University College, London

Phase 2 Not yet recruiting
40 enrolled
Gynecologic

Endometrial Neoplasms

NCT07013851 2025-06-10

NADIA

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Not yet recruiting
25 enrolled
GynecologicOther solid neoplasm

MMRd/MSI-H Stage II-III Endometrial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡